Large Cap
Pharmaceutical Preparations
Stocks Ranked by
Market Capitalization
| # | Name | Market cap | Price | Price change % | |
|---|---|---|---|---|---|
 1 Abbott ABT $183B | $183B | $105.24 | -5.62% | ||
 2 Pfizer PFE $174B | $174B | $30.77 | +1.66% | ||
 3 Vertex Pharmaceuticals VRTX $128B | $128B | $495.26 | +0.56% | ||
 4 Regeneron Pharmaceuticals REGN $119B | $119B | $1,078.63 | +1.36% | ||
 5 Bristol-Myers Squibb BMY $102B | $102B | $50.45 | +10.87% | ||
 6 Zoetis ZTS $82.1B | $82.1B | $179.84 | -0.51% | ||
 7 Alnylam Pharmaceuticals ALNY $29.7B | $29.7B | $234.84 | -1.28% | ||
 8 Teva Pharmaceuticals TEVA $19.4B | $19.4B | $17.10 | +1.79% | ||
 9 BeiGene BGNE $17.2B | $17.2B | $162.54 | -0.45% | ||
 10 BioMarin Pharmaceuticals BMRN $16.1B | $16.1B | $84.59 | -1.17% | ||
 11 United Therapeutics UTHR $15B | $15B | $338.22 | +0.55% | ||
 12 Viatris VTRS $14.4B | $14.4B | $12.08 | +0.34% | ||
 13 Sarepta Therapeutics SRPT $13.6B | $13.6B | $144.24 | -2.5% | ||
 14 Royalty Pharma RPRX $13B | $13B | $28.79 | +0.38% | ||
 15 Insmed INSM $12.2B | $12.2B | $74.54 | +0.05% | ||
 16 Catalent CTLT $10.6B | $10.6B | $58.68 | +0.39% |